NCT03086278View on ClinicalTrials.gov

A Study of AST-008 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

August 16, 2018

Study Completion Date

August 16, 2018

Conditions
Healthy Volunteer Study
Interventions
DRUG

AST-008

AST-008 is a toll-like receptor 9 agonist.

Trial Locations (1)

SE1 1YR

Richmond Pharmacology, London

Sponsors

Lead Sponsor

Exicure, Inc.
All Listed Sponsors
lead

Exicure, Inc.

INDUSTRY